PL2586424T3 - Kompozycje farmaceutyczne zawierające antagonistę receptora angiotensyny II, hydrochlorotiazyd i środek rozsadzający - Google Patents
Kompozycje farmaceutyczne zawierające antagonistę receptora angiotensyny II, hydrochlorotiazyd i środek rozsadzającyInfo
- Publication number
- PL2586424T3 PL2586424T3 PL13150074T PL13150074T PL2586424T3 PL 2586424 T3 PL2586424 T3 PL 2586424T3 PL 13150074 T PL13150074 T PL 13150074T PL 13150074 T PL13150074 T PL 13150074T PL 2586424 T3 PL2586424 T3 PL 2586424T3
- Authority
- PL
- Poland
- Prior art keywords
- hydrochlorothiazide
- disintegrant
- angiotensin
- receptor antagonist
- pharmaceutical combinations
- Prior art date
Links
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 title 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 title 1
- 229940126317 angiotensin II receptor antagonist Drugs 0.000 title 1
- 239000007884 disintegrant Substances 0.000 title 1
- 229960002003 hydrochlorothiazide Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/04754A TR201004754A1 (tr) | 2010-06-11 | 2010-06-11 | Yeni Farmasötik Kombinasyonlar |
| EP13150074.6A EP2586424B1 (en) | 2010-06-11 | 2011-06-10 | Pharmaceutical combinations comprising an angiotensin II receptor antagonist, hydrochlorothiazide and a disintegrant. |
| EP11169599.5A EP2394638B1 (en) | 2010-06-11 | 2011-06-10 | New pharmaceutical combinations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2586424T3 true PL2586424T3 (pl) | 2015-03-31 |
Family
ID=43303905
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13150074T PL2586424T3 (pl) | 2010-06-11 | 2011-06-10 | Kompozycje farmaceutyczne zawierające antagonistę receptora angiotensyny II, hydrochlorotiazyd i środek rozsadzający |
| PL11169599T PL2394638T3 (pl) | 2010-06-11 | 2011-06-10 | Nowe połączenia farmaceutyczne |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11169599T PL2394638T3 (pl) | 2010-06-11 | 2011-06-10 | Nowe połączenia farmaceutyczne |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110305757A1 (pl) |
| EP (2) | EP2394638B1 (pl) |
| DK (1) | DK2394638T3 (pl) |
| ES (2) | ES2424469T3 (pl) |
| PL (2) | PL2586424T3 (pl) |
| PT (1) | PT2394638E (pl) |
| TR (1) | TR201004754A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201007508A1 (tr) * | 2010-09-14 | 2012-04-24 | Sanovel İlaç San. Ve Ti̇c. A.Ş. | Oral yolla dağılan bileşimler |
| KR101414873B1 (ko) * | 2012-06-28 | 2014-07-03 | 보령제약 주식회사 | 피마살탄 및 히드로클로로티아지드가 함유된 약제학적 조성물 |
| WO2014102628A1 (en) * | 2012-12-31 | 2014-07-03 | Ranbaxy Laboratories Limited | Stable pharmaceutical composition comprising azilsartan medoxomil |
| CN107661302B (zh) * | 2016-07-29 | 2021-08-27 | 武汉朗来科技发展有限公司 | 一种口服固体制剂及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2125251C (en) * | 1993-06-07 | 2005-04-26 | Yoshiyuki Inada | A pharmaceutical composition for angiotensin ii-mediated diseases |
| JPH11508894A (ja) * | 1995-06-30 | 1999-08-03 | メルク エンド カンパニー インコーポレーテッド | Ａｃｅ阻害剤とａｉｉ拮抗薬を用いる腎疾患の治療方法 |
| MX2010009990A (es) * | 2008-03-11 | 2010-12-15 | Depomed Inc | Formas de dosificación gástricas retentivas de liberación prolongada que comprenden combinaciones de un analgésico no opioide y un analgésico opioide. |
| EA201001312A1 (ru) * | 2008-03-19 | 2011-04-29 | Рациофарм Гмбх | Твердая фармацевтическая композиция, содержащая непептидный антагонист рецептора ангиотензина ii и диуретик |
| UY32126A (es) * | 2008-09-25 | 2010-04-30 | Takeda Pharmaceutical | Composición farmacéutica sólida |
-
2010
- 2010-06-11 TR TR2010/04754A patent/TR201004754A1/xx unknown
-
2011
- 2011-06-10 ES ES11169599T patent/ES2424469T3/es active Active
- 2011-06-10 DK DK11169599.5T patent/DK2394638T3/da active
- 2011-06-10 ES ES13150074.6T patent/ES2522873T3/es active Active
- 2011-06-10 PL PL13150074T patent/PL2586424T3/pl unknown
- 2011-06-10 EP EP11169599.5A patent/EP2394638B1/en not_active Not-in-force
- 2011-06-10 EP EP13150074.6A patent/EP2586424B1/en not_active Not-in-force
- 2011-06-10 PT PT111695995T patent/PT2394638E/pt unknown
- 2011-06-10 PL PL11169599T patent/PL2394638T3/pl unknown
- 2011-06-13 US US13/159,049 patent/US20110305757A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT2394638E (pt) | 2013-08-22 |
| DK2394638T3 (da) | 2013-07-15 |
| US20110305757A1 (en) | 2011-12-15 |
| ES2522873T3 (es) | 2014-11-18 |
| TR201004754A1 (tr) | 2012-01-23 |
| ES2424469T3 (es) | 2013-10-02 |
| PL2394638T3 (pl) | 2014-02-28 |
| EP2394638A1 (en) | 2011-12-14 |
| EP2394638B1 (en) | 2013-05-08 |
| EP2586424B1 (en) | 2014-08-13 |
| EP2586424A1 (en) | 2013-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2424433A4 (en) | MULTIMODE PORTABLE PATIENT MONITORING SYSTEM | |
| EP2213274A4 (en) | DRUG DELIVERY SYSTEM, AND DRUG DELIVERY DEVICE | |
| EP2542744A4 (en) | TRANSITIONAL AUTHENTICATION SYSTEM | |
| IL237392A0 (en) | Pharmaceutical combination | |
| ZA201101737B (en) | Progestin-containing drug delivery system | |
| ZA201108587B (en) | Disubstituted phthalazine hedgehog pathway antagonists | |
| AP2010005341A0 (en) | Solid pharmaceutical dosage form | |
| EP2526908A4 (en) | DECISION MANAGEMENT SYSTEM, SEPARATION RECOGNITION AND RECORDING DEVICE | |
| EP2400883A4 (en) | SYSTEMS AND METHODS FOR ACTIVE EXTRACTION MANAGEMENT | |
| SG10201700715SA (en) | Drug delivery device | |
| IL200547A0 (en) | Multiple vial drug mixing system | |
| BRPI1013187A2 (pt) | comprimido, e, po granulado | |
| AP2012006276A0 (en) | New CCR2 receptor antagonists and uses thereof. | |
| AP2012006351A0 (en) | Payment message routing using geo-location. | |
| SI2655375T1 (sl) | Derivati pirimidinona, njihova priprava in njihova farmacevtska uporaba | |
| EP2555036A4 (en) | ENDOSCOPIC DEVICE AND CONNECTION UNIT FOR ENDOSCOPE DEVICE | |
| AP2011005687A0 (en) | Sustained release drug delivery system. | |
| IL222851A0 (en) | Substituted heterocyclyl benzyl pyrazoles, and use thereof | |
| GB0819565D0 (en) | Barrier system | |
| GB201000119D0 (en) | A camera arrangement, camera system and method | |
| GB2499527B (en) | Riserless, pollutionless drilling system | |
| SI2252273T1 (sl) | Trdni farmacevtski sestavek, ki obsega nepeptidni antagonist receptorja angiotenzina II in diuretik | |
| IL208953A0 (en) | Pharmaceutical combination | |
| PL2586424T3 (pl) | Kompozycje farmaceutyczne zawierające antagonistę receptora angiotensyny II, hydrochlorotiazyd i środek rozsadzający | |
| IL225709A0 (en) | Security barrier system |